Clinical Trial Update: Phase II of Zactima Maintenance for Locally Advanced or Metastatic Non-small-cell Lung Carcinoma (NSCLC) Following Platinum-doublet Chemotherapy [Phase 2]

View source ↗

Summary

Phase II results from a maintenance therapy study of Zactima for locally advanced or metastatic non-small-cell lung cancer following platinum-doublet chemothera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Zactima (vandetanib)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: NSCLC | Phase 2 | Status: COMPLETED | Results posted: 2011-07-08